indications for glp-1 Beyond Injections: How Oral GLP-1s Will Fit into Obesity Care The updated GLP-1 & GIP

The problem was the side effects associated, particularly with GLP-1, are what we call peak to trough: so the difference between the highest amount of drug and the lowest and then going back up again to the highest caused by this twice-a-day dosingwhich you can imagine someone bouncing around maybe two to three times, the drug at peak, then trough, causes a lot of GI distress

This rebound effect contributes significantly to weight regain patterns observed after cessation of appetite-modifying medications

G.MeharieB

Fewer obesity cases could lead to decreased demand for medical interventions related to diabetes, cardiovascular diseases, and other weight-related conditions, thus reallocating healthcare funds more efficiently